ELUCIDATING THE MODULATORY ROLE OF DOPAMINE IN THE C. ELEGANS CHEMOSENSORY ASH NEURON by Kunkel, Cory
California State University, San Bernardino 
CSUSB ScholarWorks 
Electronic Theses, Projects, and Dissertations Office of Graduate Studies 
8-2021 
ELUCIDATING THE MODULATORY ROLE OF DOPAMINE IN THE C. 
ELEGANS CHEMOSENSORY ASH NEURON 
Cory Kunkel 
Follow this and additional works at: https://scholarworks.lib.csusb.edu/etd 
 Part of the Behavioral Neurobiology Commons, and the Molecular and Cellular Neuroscience 
Commons 
Recommended Citation 
Kunkel, Cory, "ELUCIDATING THE MODULATORY ROLE OF DOPAMINE IN THE C. ELEGANS 
CHEMOSENSORY ASH NEURON" (2021). Electronic Theses, Projects, and Dissertations. 1281. 
https://scholarworks.lib.csusb.edu/etd/1281 
This Thesis is brought to you for free and open access by the Office of Graduate Studies at CSUSB ScholarWorks. It 
has been accepted for inclusion in Electronic Theses, Projects, and Dissertations by an authorized administrator of 
CSUSB ScholarWorks. For more information, please contact scholarworks@csusb.edu. 
ELUCIDATING THE MODULATORY ROLE OF DOPAMINE IN THE C. 
ELEGANS CHEMOSENSORY ASH NEURON 
 
A Thesis 
Presented to the 
Faculty of 




In Partial Fulfillment 
of the Requirements for the Degree 









ELUCIDATING THE MODULATORY ROLE OF DOPAMINE IN THE C. 
ELEGANS CHEMOSENSORY ASH NEURON 
 
A Thesis 
Presented to the 
Faculty of 









Michael Chao, Committee Chair, Biology 
 
Angela Horner, Committee Member 
 
Daniel Nickerson, Committee Member 
 




The neurotransmitter dopamine regulates chemosensory avoidance 
behavior in the model organism Caenorhabditis elegans. Avoidance behaviors 
are mediated by the polymodal ASH nociceptive sensory neurons, and 
behavioral avoidance of stimuli detected by ASH is less robust when dopamine 
signaling is impaired. We are investigating the neural response of the ASH 
neurons to various stimuli; our investigation includes the behavioral and 
physiological responses from the ASH neurons as dopamine signaling is 
manipulated to better understand the effects of dopamine on these sensory 
neurons. We hypothesize that dopamine plays a regulatory role on the ASH 
neurons, lessening the response of the ASH neuron to noxious environmental 
stimuli while the animal is in the presence of adequate food resources. 
Behavioral assays revealed that cat-2 mutants, which are dopamine deficient, 
had decreased behavioral response to the bitter tastant quinine compared to 
wildtype animals. In addition, normal response to quinine was restored to cat-2 
mutant animals in the presence of exogenous dopamine. Using a custom 
microfluidics device and the transgenically-expressed Ca2+ sensor GFP variant 
G-CaMP, we found that intracellular [Ca2+] changes in ASH neurons mirrors the 
behavioral responses in wildtype and cat-2 mutants, and that exogenous 
dopamine restores grossly normal response to cat-2 mutants. The dop-1 and 
dop-4 dopamine receptor mutants had similar behavioral responses to quinine as 
the cat-2 mutant while being resistant to exogenous dopamine. However, both 
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the dop-1 and dop-4 receptor mutants showed increased Ca2+ influx in ASH 
neurons when compared to wildtype animals. Collectively our data suggests that 
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CHAPTER ONE:  
INTRODUCTION 
1.A. The Neurotransmitter Dopamine is a Monoamine with many Biological 
Functions 
Neurotransmitters are small organic molecules that are utilized by neurons 
to transmit chemical signals between individual or groups of cells. 
Neurotransmitters can be classified based upon the structure of the transmitter 
molecule. The monoamine class of neurotransmitters includes dopamine, 
serotonin, epinephrine, and norepinephrine; dopamine, epinephrine and 
norepinephrine can further be categorized as catecholamines (Li et al., 2017). 
The monoamine neurotransmitters are defined by their containing a single amine 
group. Deficits in monoamine neurotransmitter signaling have been found to be 
correlated with various ailments and diseases (Di Giovanni et al., 2016). 
1.B. Dopamine Plays a Key Role in Several Neurological Diseases in Humans 
Dopamine is known to play multiple critical roles within the human nervous 
system. It is associated with the control of the locomotor actions, emotion, 
cognition, sleep/wake cycles, and regulation of the neuroendocrine system 
(Gugliandolo et al.; Korshunov et al., 2017; Oishi and Lazarus, 2017; Stoker et 
al., 2017; Volkow et al., 2004). 
1.B.1. Parkinson’s Disease and Dopamine   
One important dopaminergic system in humans involves the dopamine 
synthesizing region of the midbrain, the substantia nigra compacta. The 
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substantia nigra innervates the region known as the dorsal striatum, and this 
pathway is collectively called the nigrostriatal pathway. It is associated with motor 
control, and degeneration of this particular brain region results in Parkinson's 
disease (Lang and Lozano, 1998; Vallone et al., 2000). The causes of 
Parkinson’s disease remain unclear, though many possibilities are being 
researched. Researchers are looking to genetics, harmful neurotoxins, 
maladaptive biochemistry, and environmental factors as possible culprits leading 
to Parkinson’s disease symptoms (Triarhou, 2013).  
Parkinson’s disease is best characterized by the death of dopaminergic 
neurons of the midbrain, reducing the amount of dopaminergic projections 
connecting to the striatum. The decrease in dopamine within the system 
manifests as a disruption of body movements; these disruptions appear as 
hypokinesia, a decrease in the amplitude and frequency of voluntary movement, 
or bradykinesia, a reduction in the overall speed of movement. In addition to the 
locomotory deficits, Parkinson’s disease patients frequently suffer from sensory 
neuron malfunctions manifesting as tingling and pain within the limbs (Rodriguez-
Oroz et al., 2009). Increased knowledge gained by research into the basic 
biological functions of dopamine could aid in the future design of treatments for 
individuals with Parkinson’s disease. 
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1.B.2. Drug Addiction and the Role of Dopamine in the Mesolimbic Reward 
Pathway 
  Drug abuse is a social concern costing the United States of America 
billions of dollars a year in treatment, prevention, and law enforcement (Harwood 
et al., 1984; Mark et al., 2001). Animal models have and will continue to be useful 
tools in the ongoing quest to understand and thus treat the underlying biological 
processes resulting in drug addiction (Engleman et al., 2016). 
Dopamine plays an integral role in drug addiction (Chiara and Imperato, 
1988; Volkow et al., 2004, 2009). Dopamine levels tend to be increased during 
drug addiction. Both amphetamines and cocaine reportedly increase levels of 
dopamine release in both the striatum and the nucleus accumbens by up to 
tenfold and opiates are reported to increase levels of synaptic dopamine (Chiara 
and Imperato, 1988).  
1.C. Dopamine is Found in a Wide Range of Organisms 
Dopamine is a conserved neurotransmitter and is utilized in a wide range 
of organisms from relatively simple nematodes to more complex organisms such 
as mammals. Some species of dinoflagellates utilize dopamine to regulate water 
column migration in response to sunlight cues (Forward, 1977). Fruits and 
vegetables utilize dopamine as a powerful antioxidant molecule to keep fruiting 
bodies from browning (Udenfriend et al., 1959). Dopamine has even been 
identified in interspecies interactions such as a host defense response to 
infectious pathogens (Lyte and Ernst, 1993). Some wasps have been known to 
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inject dopamine into cockroaches in order to control the cockroaches’ behavior 
so that the cockroaches do not respond to injected wasp larvae (Weisel-Eichler 
et al., 1999). Infectious fungi utilize host produced dopamine in melanin 
production in cases of meningitis infections (Williamson et al., 1998). Clearly 
dopamine is a widely utilized molecule across a wide breadth of taxa.  
1.C.1. Dopamine Biosynthesis 
Dopamine is synthesized within the neurites (both dendritic and axonal) of 
dopaminergic neurons from the amino acid precursor tyrosine. The rate limiting 
step in the conversion reaction of tyrosine to dopamine is catalyzed by the 
enzyme tyrosine hydroxylase. Tyrosine hydroxylase converts tyrosine to L-3,4-
dihydroxyphenylalanine (L-DOPA), which is then converted to dopamine by the 
enzyme L-amino acid decarboxylase (Al-Baradie, 2002). The presence of the 
gene coding for this tyrosine hydroxylase enzyme, encoded by the cat-2 gene in 
C. elegans, has been used to define the presence of dopamine within a species 
(Sulston et al., 1975; Vallone et al., 2000).   
1.C.2. Signaling Through Dopamine Receptors 
Most dopamine receptors are members of the seven-transmembrane 
domain G-protein coupled receptors; other receptors such as ligand gated 
chloride channels found in invertebrates can also be activated dopamine (Green 
et al., 1996; Ringstad et al., 2009). To date, researchers have characterized five 
unique DA receptors (Kerr and Wickens, 2001; Meador-Woodruff et al., 1992) 
within mammals. Based upon pharmacological and biochemical attributes, they 
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have been classified into two main groups: the D1 type (D1 and D5) and D2 type 
(D2, D3, and D4) receptors (Tarazi et al., 2001). Both receptor types contain 
regions on the C-terminus that contain phosphorylation and palmitoylation sites, 
which are thought to be involved in agonist-dependent desensitization of 
receptors (Bates et al., 1991; Journot et al., 1987).  
D1 and D2 receptors are frequently antagonistic to each other; this 
antagonistic nature allows for the control of motor movements dopamine 
signaling (Jorgensen, 2004). The D1 and D2 like receptors can achieve this 
antagonistic regulatory relationship via the activation of different specific 
intracellular targets. D1 receptors activate adenylyl cyclase, increasing levels of 
cyclic AMP within the cell (Le Crom et al., 2003) which activates protein kinase A 
(PKA). Within neurons, PKA is known to phosphorylate various proteins including 
ion channels, and this alters their conductive properties and affects the 
excitability of neurons. The D2 like receptors on the other hand are able to act 
antagonistically to the D1 type receptors by negatively regulating cAMP levels via 
inhibition of adenylyl cyclase (Beaulieu and Gainetdinov, 2011). For instance, 
activation of D1 receptors leads to increased Ca2+ currents within the cell 
(Missale et al., 1998). 
1.D. C. elegans is an Ideal Model Organism for the Study of the Neuro-
modulatory Activities of Dopamine 
Research into the basic biological functions of dopamine and dopamine 
receptor activity is relevant in the treatment and understanding of the human 
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conditions associated with dopamine activity. The study of basic function can be 
carried be carried out in a multitude of organisms (See section 1C.). For this 
study, we have chosen the model organism Caenorhabditis elegans for a variety 
of reasons. 
1.D.1. C. elegans is a Lab Model Organism with a Rapid Life Cycle 
C. elegans is a small, free-living, soil inhabiting nematode worm that is a 
well understood and widely used model organism within multiple research 
subfields of biology, including neurobiology. C. elegans are mainly found as 
hermaphrodites that produce both oocytes and sperm allowing for self-
fertilization; this aspect of the species allows for the maintenance of genetically 
inbred lines (Brenner, 1974). Groups of C. elegans animals can be maintained on 
small Petri dishes filled with agar and a bacterial food source; on these plates, 
animals will develop through four larval stages (L1-L4) before becoming a 
sexually reproducing adult. The maturation of C. elegans animals is dependent 
upon the temperature of the environment ranging from three to five days (15-
25⁰C) (Blaxter, 2011; Byerly et al., 1976). Large numbers of C. elegans can be 
maintained within the laboratory for minimal cost and effort (Engleman et al., 
2016; Sulston et al., 1975). One additional significant benefit to the use of C. 
elegans as a model organism is that the animal is transparent, which allows for 
easy imaging of internal structures in vivo (White et al., 1986) . As an 




1.D.2. C. elegans has been Investigated with a Wealth of Genetic Tools 
C. elegans can be genetically manipulated relatively easily by utilizing 
ethyl methanosulphonate (EMS) as a random mutagen (Brenner, 1974), 
producing libraries of mutants (White et al., 1986). C. elegans can also be 
manipulated through reverse genetics, such as the addition of extrachromosomal 
arrays via transgene injection into oocytes; these transgenic arrays can be 
passed along to the progeny as semi-stable episomes (Mello et al., 1991). 
Another reverse genetics tool that C. elegans can be investigated with is RNA 
interference (RNAi). Injections of dsRNA into worms can selectively block the 
activities of genes complimentary to the injected dsRNA (Gönczy et al., 2000; 
Tabara, 1998). One of the newest tools for C. elegans reverse genetics is that of 
CRISPR (clustered regularly interspaced short palindromic repeats) driven 
recombination; this new procedure allows for the creation of both knock-ins 
(addition of gene/function) and knock-outs (loss of function mutations) at 
precisely engineered locations, allowing for editing of nearly any genomic region 
of the species (Chen et al., 2013; Friedland et al., 2013; Gaj et al., 2013). Of 
particular interest are the varieties of isolated mutant strains exhibiting behavioral 
differences or aberrations when compared to wildtype worms. Mutations in single 
genes that lead to differences in behavior illustrate the effect of genetics on the 
behavior. This is particularly interesting as these mutations in single genes can 
lead to an understanding of the molecular mechanisms of behavior. 
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1.D.3. C. elegans as a Model for Studying Drug Abuse 
C. elegans has been used as a model to study the molecular and cellular 
mechanisms underlying drugs of abuse, including that for alcohol (Wolf and 
Heberlein, 2003), nicotine (Waggoner et al., 2000), cocaine (Musselman et al., 
2012), and methamphetamines (Schreiber and McIntire, 2011). Invertebrate 
models offer the ability to relatively easily examine molecular frameworks of drug 
addiction in a cost-effective way. C. elegans offers an array of well understood 
behaviors to use in investigative assays ranging from egg laying to locomotor 
gaits (Engleman et al., 2016). The C. elegans genome is completely sequenced 
with approximately 19,000 protein coding genes, allowing for the study of basic 
biological attributes of specific molecules. This study will utilize the cat-2 mutant 
strain of C. elegans that is deficient in dopamine biosynthesis (Sanyal et al., 
2004) (See section 1.C.1), to aid in the investigation of the function of dopamine. 
This mutant strain of C. elegans is especially useful due to the fact that in other 
models, such as the in the common lab mouse Mus musculus, deficits in 
dopamine production can be lethal during fetal development and so are of limited 
use to researchers (Zhou et al., 1995).  
1.D.4. C. elegans Utilizes Dopamine for Various Functions 
Much has been determined about the functions of dopamine within the C. 
elegans nervous system. Dopamine is believed to be released during times that 
the animal is in the presence of an abundant food source; the increased release 
of dopamine in turn make the animal more sensitive to aversive stimuli within the 
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environment. The logic of this premise is such that animals in an environment 
that is plentiful in food can afford to be more selective in food choice, avoiding 
noxious substances, in comparison to an animal that is in a food poor 
environment.  
1.E. Dopamine Plays a Regulatory Role Over many Functions and Behaviors 
1.E.1. Locomotion and Food Searching 
Animals such as nematodes must locomote to survive. Locomotion is a 
rich area of behavioral research and has offered many insights into the 
neurobiology of C. elegans. Dopamine has been shown to play a role in multiple 
C. elegans locomotory behaviors. C. elegans motor circuits do not function in a 
deterministic process; instead, sensory inputs affect a continual repetitive series 
of neuromuscular activities. In other words, animals do not “decide” on a given 
locomotory path but instead have been shown to locomote in response to 
environmental cues. Behaviors such as this are carried out via a chain of 
neurons that can start with sensory neurons communicating with command 
interneurons; these interneurons are able to elicit effects on motor neurons, 
causing abrupt changes to direction of locomotion including the initiation of a 
reversal, or the abrupt change of direction of locomotion. The command 
interneurons retain some control over locomotion in animals which have had the 
sensory neurons ablated, indicating the power these command interneurons 
exhibit over neuromuscular activity. Studies of C. elegans on graded plates 
(plates possessing a gradient of a given chemical that a worm may or may not 
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find attractive) have shown that the sensory neurons themselves are responsible 
for the "mapping" of chemical stimuli in the animals’ environment (Sengupta and 
Samuel, 2009). 
An example of dopamine-driven behavior is the slowing of well-fed 
animals when placed on a new food source; this basal slowing is enhanced if the 
animals in question are not well-fed, indicating a likely role of dopamine signaling 
in the regulation of this behavior. Animals deficient in dopamine did not exhibit 
basal slowing; the basal slowing behavior was restored to that of wildtype 
animals upon treatment with exogenous dopamine. Further, laser ablations of 
dopaminergic neurons revealed that the multiple classes of C. elegans 
dopaminergic neurons redundantly release dopamine during the activity of this 
pathway. The data gathered in this experiment suggest a role of dopamine in the 
control of basal slowing (Sawin et al., 2000; Suo et al., 2004). 
Dopamine, in tandem with glutamate, is also known to be involved in the 
regulation of the area-restricted search (ARS) behavior. This behavior is thought 
to have evolved to keep animals around abundant food sources. ARS represents 
an increase in turning rate in the presence of food allowing an animal to remain 
in a food rich immediate environment. ARS patterns will vary with the time since 
food was last encountered; the longer the amount of time since food was present 
the less amount of turning behavior. It is thought that dopamine is released in the 
presence of food to inhibit glutamate signaling, which in turn increases the 
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amount of turning exhibited to maintain the animals in the location of food 
sources (Hills et al., 2004; Vidal-Gadea and Pierce-Shimomura, 2012). 
1.E.2. Gene Expression 
Dopamine has also been found to affect gene regulation in C. elegans 
through interactions with the transcriptional factor cAMP response element 
binding protein (CREB) via G protein coupled receptors (GPCR); research has 
shown implications of this regulatory pathway in learning and drug addiction. 
Dopamine signaling through the D2-like dopamine receptors DOP-2 and DOP-3 
has been found to inhibit release of octopamine (i.e. invertebrate norepinephrine) 
upon exposure to environments containing adequate food resources. This 
inhibition of octopamine release results in an inhibition of the CREB protein and 
thus causes an effect on gene expression. Levels of dopamine within the C. 
elegans nervous system track with levels of acetylcholine. Studies have shown 
that in conditions of higher dopamine signaling resulted in lower acetylcholine 
signaling. Upon addition of exogenous dopamine there is also an observable 
decrease in acetylcholine release as well, supporting the idea that dopamine 
influences acetylcholine release. This responsive change in neurotransmitter 
release is slow as the changes depend upon the activity of CREB and CREB 
being a transcription factor works slower than other signaling molecules. This is a 
prime example of dopamine signaling affecting the signaling of another 
neurotransmitter and in turn creating a change in gene expression via CREB 
inactivation (Suo and Ishiura, 2013). 
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1.F. Dopamine Receptor Activities Vary by Type  
1.F.1. The DOP-1 and DOP-3 Receptors Frequently Function Antagonistically in 
the Same Pathways 
The D1-like and D2-like dopamine receptors (See section 1.C.2.) 
frequently act antagonistically within the C. elegans nervous system. DOP-3, a 
D2-like dopamine receptor, acts to slow the animals’ locomotion. DOP-1, a D1-
like dopamine receptor, acts directly antagonistically to the DOP-3 Gα0 signaling 
pathway via the activation of the Gαq signaling, as well as the activation of PLCβ 
signaling cascade. Both receptors have been found to be co-expressed within 
cholinergic motor neurons as well as individually expressed in other neurons; 
both receptor types appear to be expressed in levels high enough to effect 
locomotion from within these cholinergic motor neurons (Chase et al., 2004). 
DOP-3 acts via Gα0 to execute inhibitory signaling of locomotion within 
ventral cord cholinergic motor neurons. The activation of the Gα0 signaling 
pathway results in the inhibition of acetylcholine release, thereby lessening or 
silencing the signals from the cholinergic motor neurons (Allen et al., 2011). The 
activation of the Gαq signaling pathway results in the stimulation of acetylcholine 
release. Thus, the release of dopamine into the C. elegans nervous system can 
result in the animals’ ability to fine tune locomotory activities. Other similar 
studies suggest that this antagonistic/regulatory relationship between the DOP-
3/DOP-1, D2-like/D1-like, dopamine receptors is conserved in mammals (Allen et 
al., 2011; Chase et al., 2004). At the cellular level the system of control over 
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locomotory function via co-expressed D1-like and D2-like dopamine receptors is 
conserved in mammals within the medium spiny cholinergic neurons of the 
striatum region of the central nervous system, although the precise location of 
these receptors and thus the specific mode of activity during signaling remains 
unknown in mammals (Allen et al., 2011).  
DOP-1 and DOP-3 have also been implicated in C. elegans “choice” 
making between aversive stimuli. This “choice” is defined as the animal’s 
willingness to cross a barrier of diacetyl or Cu2+. They are thought to 
antagonistically regulate behavioral choice via their respective targets. For this 
particular behavioral choice pathway between aversive stimuli, the DOP-1 
receptor is thought to function in cholinergic neurons and the DOP-3 receptor in 
GABAergic neurons (Wang et al., 2014). 
C. elegans naturally exhibit an increase in odorant sensitivity when 
dopamine signaling is stimulated, such as in times of rich food resources are 
present. While investigating the role of the various dopamine receptors in this 
sensory pathway (Ezak and Ferkey, 2010), the dop-3 receptor mutant animals 
are the only strain to exhibit a significant increase in the amount of time required 
for response to 100% octanol. The data generated for the dop-3 mutant animals 
suggests that the DOP-3 receptor is required for this enhanced sensitivity to 
100% octanol. This activity has been exhibited both in vivo in the presence of 
adequate food resources and in the presence of artificially increased exogenous 
dopamine. The role of endogenous dopamine signaling in this pathway is 
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supported by the phenotypic characteristics of the dopamine deficient cat-2 
animals; the cat-2 animals do not exhibit the enhanced sensitivity to the octanol 
stimulus in comparison to the wildtype control animals.  DOP-3 expression as 
assessed by transcriptional GFP reporter transgenes was not observed in either 
of the sensory neurons ASH, ASI, or in any of the command interneurons. 
However, transgenic expression of the DOP-3 receptor within the ASH neurons 
was sufficient to modulate the animals’ response to aversive stimuli such as 
octanol. These findings, in tandem with that of the cat-2 and dop-3 mutant 
animals remaining hypersensitive to octanol exposure, suggest that dopamine 
likely acts to dampen the signals from the chemosensory neurons themselves. 
Cell specific RNAi knock-downs of the DOP-3 genes were created within the 
ASH neurons using the ASH specific promoters osm-10 and sra-6; this resulted 
in hypersensitivity to octanol that matched the behavior of the dop-3 mutants. 
Data from this experiment further supports the idea that DOP-3 is naturally 
expressed in the ASH neurons, and so is in position to modulate the animals’ 
responses to aversive stimuli. The fact that the DOP-3 receptors were not 
observed to be expressed in the ASH neurons might be explained by the 
technical limitations of C. elegans transgenic reporter genes. Interestingly, the 
DOP-1 receptor does not play any antagonistic role within this octanol sensation 
pathway (Ezak and Ferkey, 2010). 
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1.F.2. The DOP-2 Receptor is Associated with Various Homeostatic Functions 
The DOP-2 receptor is known to negatively regulate various behaviors 
including egg laying, locomotion, defecation and feeding. This had been 
illustrated using DOP-2 antagonists to block dopamine signaling by DOP-2 
receptors (Suo et al., 2004). Researchers have utilized yeast two-hybrid assays 
to show that the DOP-2 receptor interacts with the Gαi subunit, GPA-14 which is 
unique to C. elegans. The results support the idea that GPA-14 subunit in fact, 
physically associates with the DOP-2 receptor and so likely acts in an inhibitory 
fashion. Though no known homologs exist in mammals, the characteristics of this 
GPA-14 subunit have been sufficient to describe the likely activities of this 
subunit to be similar to the mammalian inhibitory G proteins (Pandey and 
Harbinder, 2012). 
Activated D2-like receptors are known to negatively regulate adenylyl 
cyclase. D2-like receptors are known to negatively regulate Ca2+ currents via 
interactions with Gαi/o subunits. This regulation is thought to in part have a 
regulatory action on the biosynthesis of dopamine; some D2-like receptors are 
found to be both pre- and post-synaptic, poised to regulate the activity of tyrosine 
hydroxylase (See section 1.C.1), which is Ca2+ dependent (Suo et al., 2003). D2-
like receptors are also known to regulate K+ currents within the cell via 
interactions with different G proteins (Jackson and Westlind-Danielsson, 1994). 
D2-like receptors located on both pre and post synaptic neurons are able to elicit 
the down regulation of cAMP levels (Suo et al., 2003).  
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1.F.3. The DOP-4 Receptor is an Additional D1-like Receptor 
The DOP-4 receptor is an analog to the DOP-1 receptor as it too is a D1-
like dopamine receptor. Interestingly, studies have indicated that the DOP-4 
receptor is functionally active in the ASH neuron. Avoidance behavior to Cu2+ 
and glycerol in the dop-4 mutant strain is diminished in relation to wildtype 
behavior; studies have shown that genetic rescues using either native promoters 
or those that are ASH specific are adequate to restore the mutant behavior to 
that of the wildtype animals (Ezcurra et al., 2011). Studies conducted on the 
expression patterns of the DOP-4 receptors using GFP reporter fusion assays 
indicate that the DOP-4 receptors are expressed in many head and sensory 
neurons, but are not expressed in the ASH neurons (Sugiura et al., 2005). This 
contradiction in expression patterns and functional patterns of the DOP-4 
receptors creates an interesting topic for future research. 
1.G. Dopaminergic Circuits within C. elegans 
Dopamine has been shown to act synaptically and extra-synaptically 
within the C. elegans nervous system. The aforementioned dopamine regulation 
of cholinergic motor neurons is a prime example of this. These ventral cord 
cholinergic motor neurons do not share synaptic connectivity with any of the 
dopaminergic neurons within the C. elegans nervous system (Fig. 1). This lack of 
connectivity indicates that dopamine must act on these neurons extra-
synaptically or humorally as a neuro-hormone (Chase et al., 2004). The ASH 
neurons do not share any direct synaptic connections with dopaminergic 
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neurons; thus, if dopamine does play a regulatory role on the ASH neurons 
themselves it might act in an extra-synaptic fashion, or dopamine might affect the 
activity of the ASH neuron via connections with other neighboring neurons 
(Ezcurra et al., 2011; Komuniecki et al., 2014). 
1.G.1. C. elegans Dopaminergic Neurons 
The C. elegans nervous system contains eight dopaminergic neurons. In 
the head can be found a pair of ADE neurons, in the nose two pairs of CEP 
neurons, and in body can be found a pair of PDE neurons (Fig. 1) (Bargmann, 
2006; Sulston et al., 1975). C. elegans dopaminergic neurons are likely able to 
sense bacterial food resources by direct mechanosensory perception (Kindt et 
al., 2007; Sawin et al., 2000). Animals in the presence of food exhibit an 
increased sensitivity to soluble repellents (See section 1.D.4.C.1.A.). This 
behavior has been shown to be directly dependent upon the ability of 
dopaminergic neurons to sense food in the immediate surrounding environment, 
such as the ASH mediated behavioral response to aqueous Cu2+ (Ezcurra et al., 
2011). This is an example of dopamine modulated behaviors related to the food 
resource qualities in the environment. 
1.H. C. elegans Expresses Multiple Sensory Neurons Dedicated to the Sensation 
of Environmental Stimuli 
The C. elegans hermaphroditic (See section 1.D.1) nervous system is 
comprised of precisely 302 neurons. This relatively small number of individual 
neurons comprising the nervous system is a benefit to research as the location 
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and connectivity of each neuron has been largely identified. C. elegans neurons 
can be grouped into a total of 118 classes of neurons; 20 of the 302 neurons can 
be classified as pharyngeal and the remaining 282 as somatic (Hall and Russell, 
1991; Varshney et al., 2011; White et al., 1986).  
Environmental nutritional conditions are a key influence on C. elegans 
behavior (Komuniecki et al., 2014). For instance, in times of abundant food 
supply C. elegans are known to be more sensitive in aversive stimuli such as the 
heavy metal Cu2+ (Ezcurra et al., 2011).  The N2 wildtype reference strain of C. 
elegans is known to gather in clumps containing many animals when food is 
limited in the environment, whereas more “social” strains will exhibit this behavior 
when food is not limited (de Bono and Bargmann, 1998). 
C. elegans have 16 pairs of sensory neurons. These neurons are found in 
pairs and are classified by the following names: ASE, AWC, AWA, AWB, ASH, 
ASI, ADF, ASG, ASJ, ASK, ADL, URX, AQR, PQR, PHA, and PHB. These 
sensory neurons synapse on interneurons and undergo integration prior to 
synapses with command interneurons, which elicit changes in locomotory 
behavior directly (Bargmann, 2006; Komuniecki et al., 2014). 
1.H.1. The Amphid Pore is the Nematode’s “Nose” 
Many of the C. elegans neurons are located in the head, forming groups of 
sensory neurons called sensilla. Two of these sensilla are relatively large and 
form what are known as the amphid pores (Fig. 2), located on either lateral side 
of the animal. Each amphid pore contains the ciliated endings of eight sensory 
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neurons, one pair of which are the sensory neurons under investigation in this 
study, the ASH neurons (White et al.,1986). Amphid neurons also contain 
axonemal cilia, which are exposed to the external environment to aid in 
sensation. The ASH neurons are known to contain such axonemal cilia (Kaplan 
and Horvitz, 1993; White et al., 1986). One can imagine the frequently hostile 
nature of the external environment faced by worms living in soil, such as infection 
by pathogenic bacteria (Finlay, 1999; Kurz and Ewbank, 2000) or desiccation 
(Chakrabortee et al., 2007; Erkut et al., 2013). C. elegans as a species may have 
evolved this amphid pore structure to protect the delicate terminal receptors of 
the sensory neurons.  
This unique structure of the amphid pores suggest that the amphid 
sensory neurons represent the major chemoreceptor neurons of the C. elegans 
nervous system. Laser ablation of these amphid neurons, such as ASE or ASK 
neurons, result in the inability of the animal to properly sense its native 
environment (Calhoun et al., 2015; Troemel et al., 1995). There exists a similar 
structure in the tail of the C. elegans worm known as the phasmid, which is also 
associated with gathering sensory information from the environment (Hall and 
Russell, 1991; White et al., 1986). 
1.H.2. The ASH Neuron is a Polymodal Sensory Neuron that Drives Dopamine 
Sensitive Behaviors 
The bilaterally paired C. elegans ASH neurons exhibit diverse capabilities 
of sensing aversive stimuli in the immediate environment as polymodal sensory 
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neurons. This includes stimuli such as high osmolarity, nose touch, volatile 
chemicals, bitter tastants, and feeding behaviors in social settings (Bargmann, 
2006; Ezak and Ferkey, 2010). The ASH neurons function as both chemo- and 
mechanosensory neurons similar to the vertebrate nociceptor neurons that are 
associated with the perception of pain in the vertebrate system (Kaplan and 
Horvitz, 1993). Through behavioral analysis, the ASH neurons are known to 
sense the following noxious stimuli: Cu2+, SDS (detergent), glycerol, quinine, 
octanol, and possibly others (Ezak and Ferkey, 2010; Hilliard et al., 2005). 
1.H.3. ASH Connectivity/Receptors 
The ASH neurons are known to express a multitude of GPCRs with a suite 
of associated Gα subunits such as odr-3, gpa-3 (both expressed in large 
amounts), gpa-1, -11, -13, -14, and -15 (Bargmann, 2006) (Fig. 2). The ASH 
neurons are also known to have synaptic connections with the command 
interneurons AVD, AVB, and AVA (White et al., 1986); these synaptic 
connections allow for the ASH neurons to directly excite the command 
interneurons, stimulating them via the release of neurotransmitters such as 
glutamate and neuropeptides. This excitation of the command interneurons leads 
to a change in locomotion in response to ASH-sensed stimuli (Hart et al., 1995; 
Mellem et al., 2002).  
1.H.4. ASH Neural Modulation 
In food rich conditions the ASH neurons show an increased physiological 
response, as a quantifiable transient increase in intracellular Ca2+ levels, to both 
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Cu2+ and glycerol. In addition to an increase in the magnitude of physiological 
response, the ASH neurons also show an increase in duration of increased 
intracellular Ca2+ levels in comparison to Ca2+ levels in food poor conditions 
(Ezcurra et al., 2011). Some ASH mediated behaviors have been shown to be 
modulated by neuropeptide signaling in addition to dopamine signaling 
(Komuniecki et al., 2014). Clearly food availability influences ASH mediated 
behaviors and so we hypothesize that food availability affects the activity of the 
ASH neurons themselves, likely via dopamine signaling.  
1.I. Ca2+ is the Major Ion Responsible for the Depolarization of the Neurons in C. 
elegans  
Ca2+ is most likely the major ion responsible for the depolarization of 
neurons within the C. elegans, as the C. elegans genome lacks gene sequences 
for voltage gated Na+ channels. Ca2+ ions are associated with depolarization and 
K+ ions with hyperpolarization of C. elegans neurons (Goodman et al., 1998). 
Typically, upon stimulation of a sensory neuron, the activation of GPCRs in the 
sensory cilia results in a signaling cascade that activates Ca2+ channels such as 
the OSM-9 TRP channel found within the membranes of ASH neurons allowing 
for an influx of Ca2+ ions (Feng et al., 2006; Kahn-Kirby and Bargmann, 2006; 
Xiao and Xu, 2009) (Fig. 3). This property allows for the relatively easy 
quantification of neural activity based upon transient changes in intracellular Ca2+ 
concentration, thanks to the development of Ca2+ sensitive reporter molecules. 
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1.I.1. C. elegans Neural Activity can be Measured Non-Invasively Using Ca2+-
Sensitive Fluorescent Reporter Proteins 
For the investigation of the neural-modulatory activities of dopamine, we 
will utilize a modified green florescent protein (GFP) reporter known as G-CaMP 
(Fig. 4A) that changes fluorescence intensity with changing Ca2+ levels. G-CaMP 
consists of a circularly permutated GFP that has been linked together by the 
Ca2+-binding domain of calmodulin (Nakai et al., 2001). The calmodulin domain 
has been inserted into the GFP molecule such that the native β-barrel 
conformation is broken at low concentrations of Ca2+ (Fig. 4C); when Ca2+ levels 
increase, such as when C. elegans neurons are activated, the calmodulin domain 
changes conformation and reconstitutes the β-barrel of GFP. Thus, an increase 
in fluorescence indicates an increase in intracellular Ca2+ levels (Fig. 4C). G-
CaMP can be selectively expressed in the ASH neurons (Fig. 4B) by using ASH-
specific promoters, such as the promoters for the sra-6 or osm-10 genes; this 
approach has been previously used to measure ASH neuronal activity in other 
contexts (Guo et al., 2009; Hilliard et al., 2005; Tobin et al., 2002). 
1.J. Microfluidics Devices Offer a Novel Means of Conducting Neuro-Physiologic 
Studies on C. elegans Animals 
Microfluidics is an example of a crossroads in scientific research. 
Borrowing from the physics of fluid dynamics, biologists have adapted the use of 
microfluidic apparatuses to investigate a wealth of biological questions. 
Microfluidics can broadly be defined as an analytical approach that use fluid 
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flows on a very small (micro) scale (Mukhopadhyay, 2009). Microfluidics has 
been in use for some time in tissue engineering and single cell experiments. The 
use of microfluidics is a useful tool that has allowed neuroscientists to observe 
the activities of variety of in vivo neurons from a range of organisms, to better 
understand the ways in which neural circuits work. Microfluidics devices allow for 
a simple means of immobilizing small organisms such as C. elegans for in vivo 
imaging of cellular activities (Mondal et al., 2012). 
Many common microfluidics devices are manufactured by casting 
polydimethylsiloxane (PDMS); the PDMS polymer is transparent, allowing for 
microcopy applications. The PDMS polymer is also biologically inert providing a 
non-interactive microenvironment, and PDMS is relatively inexpensive allowing 
for the rapid production of large numbers of microfluidic devices in a short 
amount of time (Mondal et al., 2012; Schrott et al., 2009). 
In the past, elaborate protocols for the immobilization of worms had been 
developed utilizing organic glues such as cyanoacrylic glue to attach worms to 
microscope slides; though effective, these procedures are technically challenging 
and require significant time investments per animal immobilized (Richmond, 
2009). Another technique used over the years is patch clamp electro-physiologic 
recordings, which is the gold standard for neurobiologists and in many respects 
remains the standard. Yet, similar to the organic glue procedures, patch clamp 
recordings require the difficult dissection of animals ~1mm in length and results 
in the death of the animals being recorded (Goodman et al., 2012). The 
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techniques for patch clamp recordings are challenging to master. Modern 
research techniques are paving the way for the elimination of many difficult to 
control variables that are associated with invasive means of measuring neuron 
activity. Researchers have adapted microfluidics systems for the immobilization 
and study of C. elegans animals. The recording chips developed for nematode 
neurobiology allow for the immobilization of single worms, rapid and precise 
chemical stimulation, and observations of behaviors in tandem with the precise 
neural activities that drive them (Chronis et al., 2007). The use of microfluidics 
devices allows for the immobilization and recording of animals quickly and non-
invasively in a short amount of time.  
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CHAPTER TWO:  
MATERIALS AND METHODS 
2.A. Animal Maintenance 
C. elegans animals were grown using standard methods on 60 mm Petri 
dishes containing general purpose nematode growth media (NGM) (agar, 
peptone, cholesterol, 1M CaCl2, 1M MgSO4, 1M KPO4 buffer at pH=6.0). NGM is 
applied to plates via a peristaltic pump at 10 mL/plate. Food is provided to the 
animals via OP50 E. coli bacterial lawns, seeded onto the plates at 100 μL/plate. 
Animals were incubated at a range of temperatures (15-25⁰C) over a range of 
time (3-5 days) respectively (Sulston et al., 1975). 
2.A.1 Mating Protocols 
Male animals carrying transgenic arrays were created mating male N2 
animals with array carrying hermaphrodites resulting in male animals that also 
carried the array. These male array carrying animals were then mated to 
homozygous dopamine receptor mutants, representing the parental generation of 
this cross. F1 heterozygous progeny were selected for via the expression of the 
G-CaMP array as any animals expressing the G-CaMP were heterozygous for 
the given mutant gene; selected F1 individuals were singled and allowed to self-
fertilize to create F2 progeny. F2 individuals were genetically screened for the 
presence of the given mutated gene using PCR (see below). 
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2.B. C. elegans Genotyping Protocols 
Worm lysates were obtained from individual animals or from entire plates 
of worms. Plates of worms can be washed from the agar plates using worm lysis 
buffer (50 mM KCl, 10 mM Tris-HCl pH 8.3, 2.5 mM MgCl2, 0.45% NP-40, 0.45% 
Tween-20, 0.01% gelatin), pelleted in a microcentrifuge and aliquoted into PCR 
tubes. PCR tubes containing live animals were placed in a -80⁰C freezer for ~10 
minutes prior to the addition of proteinase K (10mg/mL stock solution). Complete 
reactions were then placed into a benchtop thermocycler, incubated at 60⁰C for 
60 minutes, and finished at 95⁰C for a period of 30 minutes to terminate all 
enzymatic activity.  
Each strain under investigation had DNA primers designed to aid in 
genotyping each mutant allele. The specific primers can be found in Table 1. The 
dopamine receptor mutant strains each carry a deletion mutation within the 
receptor gene allowing for relatively straightforward genotyping. The PCR 
reactions were as follows: 23 µL H2O, 3 µL 10X Taq buffer, 0.4 µL 10 mM dNTP 
mix, 1 µL left primer, 0.5 µL right primer, 0.5 µL internal primer, 0.3 µL 25 mM 
MgCl2, 0.3 µL Taq polymerase, and 1 µL worm lysate mix (sample DNA) for a 30 
µL total reaction volume. Thermocycler conditions are as follows initial 
denaturation at 94°C for 2 minutes, 35 cycles of the following sequence: 94°C 
(30 seconds), 55°C (30 seconds), 72°C (30 seconds), and a finishing polish at 
72°C for 10 minutes). Genotyping PCR products were identified via gel 
electrophoresis. Standard reactions were run on a 1.5% agarose gel at 90 volts 
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for ~90 minutes in the presence of 1X TAE buffer (1 mM EDTA, 40 mM Tris and 
20 mM Glacial acetic acid). Completed gels were viewed under a UV light 
source. 
The mutation carried by the cat-2 animals is a single point mutation 
requiring the use of restriction fragment length polymorphism (RFLP) to complete 
a genotyping experiment. The mutation in the cat-2 (e1112) allele creates an 
extra cleavage site for the DdeI restriction enzyme. This results in an extra DdeI 
fragment in the cat-2 samples that is not present in the wildtype samples and 
therefore a different RFLP pattern; we used the larger wildtype (651 base pair) 
and cat-2 (616 base pair) fragments to identify cat-2 genotype. Restriction 
enzyme reactions were designed as follows: 5.5 µL H2O, 2 µL 10X BSA, 2 µL 
10X Buffer 3, 0.5 µL DdeI, and 10 µL of sample DNA as suggested by the 
enzyme vendor. The DdeI reaction was run at 37°C for a period of 2 hours. 
Products were run in an electrophoresis apparatus that was kept on ice to reduce 
the temperature of the reaction. A 3% Metaphor gel was used to resolve closely 
sized DNA fragments, allowing for the genotyping of cat-2 animals. 
2.C. Behavioral Experiments 
Behavior was characterized by utilizing an amended protocol from 
previously published works (Hilliard et al., 2005). Experiments were carried out 
on foodless NGM plates made to contain 3% less H2O than standard NGM 
recipes to create drier plates that facilitated the absorption of the dopamine 
solution. All animals used for experimentation were young adults raised on plates 
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incubated at 20 or 25°C. 10 individuals were placed onto each plate and allowed 
to acclimate for ~5 minutes. Animals were stimulated with aqueous chemicals 
delivered via flame drawn micropipette tubes (1 MM, VWR International, 
TW100F-4). Single drops of stimuli were delivered to the agar near the tail of a 
forward locomoting animal. Capillary action carries the fluid to the animal’s nose 
and the amphid pore (Fig. 5 and section 1.D.6). The time (latency) between 
delivery of stimuli and the response of the animal (reversal of direction of 
locomotion) was recorded. Each animal on each plate was only tested once. 
Data is analyzed as the fraction of animals responding within 4 seconds over the 
total number of animals tested. 
2.D. Microfluidics Experiments 
2.D.1. Strains 
The following strains were used for this study: N2 (reference wildtype 
strain), CX10979 kyEx2865 [sra-6::GCaMP3; ofm-1::GFP] (gift from S. 
Chalasani, Salk Institute), CB1112 cat-2 (e1112), FG58 dop-4 (tm1392), LX636 
dop-1(vs101). All strains except for CX10979 were obtained from the 
Caenorhabditis Genetics Center (St. Paul, MN).  
2.D.2. Microfluidics “Chip” Production 
For our microfluidics experiments we utilized an AutoCAD file of the 
olfactory chip designed by the Chronis lab (Chronis et al., 2007) (Fig. 6); we 
received this file with much gratitude from Dr. S. Chalasani of the Salk Institute. 
From this file we had produced a mask to be spincast into a mold by the 
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Microfluidics Foundry at Stanford University. All future casting made of this mold 
were conducted using Sylgard 184 silicone elastomer (Sigma-Aldrich 761036-
5EA); Sylgard 184 is a two-part elastomer utilizing a 1:10 ration of hardener to 
elastomer. For our castings we used a 6.4g:64g mixture that was spread over the 
mold placed within a 150 mm plastic petri dish. The fresh castings were placed in 
a vacuum desiccator to remove bubbles then allowed to cure for approximately 
48 hours. Cured elastomer castings were removed from the mold, scored using a 
scalpel and individual “chips” were separated prior to punching hose ports using 
a Harris uni-core tool (internal diameter of 0.75 mm, Fisher scientific 
NC0711699). Completed chips were them adhered to microscope cover slips 
(Sigma Aldrich CLS2975245) using a corona generator (Electro-Technic 
Products, 12051A-10) for approximately two minutes at a distance of 1 cm. 
Lastly, chip and glass were pressed together, and a piece of tape is applied to 
apply pressure as well as protect chip surface until the time of use. 
2.D.3. Design of Microfluidics Fluid Delivery System 
Our microfluidics system requires the use of 5-50 mm syringes used as 
fluid reservoirs, each connected to the microfluidics chip via small diameter 
Tygon tubing (ID 0.02 in, OD 0.06 in), using male Luer lock to 0.25 -inch (length) 
barb adaptors. The other end of each tubing is connected to the fluid ports on the 
microfluidics chip itself using a small section of metallic tubing (New England 
Small Tubing, I.D. 0.017 inch—O.D. 0.025 inch). The first reservoir syringe is 
filled with M13 buffer (30 mM Tris-HCl pH 7.0, 100 mM NaCl, and 10 mM KCl) 
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(Hart, 2006) and is used to move animals into the microfluidics chip; a three-way 
Luer lock valve was added in line prior to port 1 on the recording chip (see Fig 6) 
with a 5 mL syringe added to the third port of the valve. This valve could be set 
three ways: (1) continuous between syringe and fluid reservoir, so that the 
syringe can be loaded with buffer; (2) continuous between the syringe and chip 
as a means to provide pressure or suction while loading worms; (3) continuous 
between the chip and the fluid reservoir in recording mode. To load a worm, the 
syringe was first filled with buffer. The tubing was removed from port 1 of the 
recording chip, and gentle pressure from the syringe was used to place a drop of 
liquid on an animal on a foodless NGM plate. Gentle suction was then used to 
pick worm from plate and into the tubing. The tubing was then reattached onto 
the recording chip at port 1 and gentle pressure was applied so that the worm 
could be injected into the worm trap. Pressure from this syringe was also used to 
eject worms from the recording chip post experiment into the waste fluid efflux 
via the vacuum port. Another reservoir is also filled with M13 buffer, but prior to 
reaching the chip the tubing meets a three-way solenoid valve (Warner 
Instruments, Cat. Number 64-0175(SV1)) that can switch the flow of fluid from 
one hose to another; this assembly is used as an “on/off” switch for the 
presentation of stimuli to the animal. This general setup was devised by our lab 
by a previous student, Trisha Turturro. I adapted her design to deliver our 
dopamine treatment to animals within the microfluidics chip. Another reservoir is 
again filled with M13 buffer to be exposed to the animal during rest periods. This 
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rest phase buffer reservoir is also connected to an additional three-way solenoid 
valve but attached in the reverse direction of flow as the switching reservoir. To 
this second solenoid valve is also attached an additional reservoir filled with M13 
buffer containing freshly added dopamine to treat animals prior to testing. The 
final reservoir is filled with the stimulus chemical (e.g., quinine) and has a direct 
connection to the microfluidics ship with no solenoid interruptions. Fluids were 
pulled through the microfluidics chip utilizing the house vacuum system attached 
via the same small diameter tubing used to deliver the fluids to the microfluidics 
chip. 
2.D.4. Microfluidics Chip Experimental Setup 
Individual chips were checked for defects prior to being used for an 
experiment. The protective tape was removed from the microfluidics chip and is 
used to firmly attach the microfluidics chip slide to the stage of the fluorescence 
microscope. Next the vacuum tubing is attached to the chip (port 2) and allowed 
to pull air through the microfluids chip for 15-30 minutes. All tubing coming from 
the fluid reservoirs were primed by pulling fluid through the tubing using a 5 mL 
syringe. After the tubing was primed, they were individually attached to the chip 
according to the patterns shown in figure  7. Prior to starting any recording 
experiments the flow of fluid is established and switching between fluid streams 
is robustly tested to ensure proper functioning prior to running any experiment. 
Once this was completed a small amount of immersion oil is added to the 
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underside of the microfluidics chip slide in preparation for the 60X oil immersion 
objective lens used during recording experiments.  
Experimental animals were grown on NGM plates incubated at 25⁰C. 
Individual animals were removed from the NGM growth plate (containing food) 
and transferred to an NGM plate containing no bacterial food and allowed to 
crawl around for a few minutes to “clean” the animals of bacteria prior to 
experiments. A single animal was loaded into the chip as described above. The 
animal is allowed to acclimate to chip conditions for a period of 3 minutes total, 
the last 60 seconds of which it is exposed to blue fluorescence light as the ASH 
neuron is known to be sensitive to this wavelength of light; pre-exposure to the 
fluorescent light is able to halt the ASH neuron’s sensitivity to the light exposure 
(Hilliard et al., 2005). Experimental recordings were obtained using Nikon NIS 
software and an Andor (model #: DR-328G-CO2-SIL) camera on a Nikon TU-
2000 microscope (600x total magnification) (Fig. 10A). Experimental traces were 
timed as follows: during the first 20 seconds (t0 – t20) of the recording subject 
animals were exposed to the M13 buffer solution to determine a baseline of 
fluorescence; between t20 – t50 subject animals were exposed to the 50 mM 
quinine-M13 stimulus solution for 30 sec; and finally, between t50 – t120 the 
quinine stream is switched away and animals were again exposed to only the 
M13 buffer solution. This method was utilized to determine the ASH response to 
the stimulus in each strain of animals. We used the same general recording 
procedure for the dopamine treatment experiments with the addition of a 
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prefusion of 4mM dopamine-M13 solution during the first 2 minutes the animals 
were in the microfluidics chip. 
Experimental recordings were initially compiled using the NIS Elements 
software using the NIS ND sequence acquisition function; this includes both data 
collection and initial quantification. After each recording that data self-loads for 
the time measurement function; prior to making this measurement a region of 
interest (ROI) is added to focus the measurement on the area immediately 
surrounding the neuron, eliminating external signal noise not created by the ASH 
neuron. After running the time measurement function the collected data can be 
exported to Microsoft Excel for further analysis. Data from Microsoft Excel 
spreadsheets was then imported into Igor (Wavemetrics) for analysis of each 
recording trace. The procedure was designed to baseline correct each trace, 
determine the maximum fluorescence, the integral of the trace, the initial slope of 
response, and the total time of activity. All data points were then transferred to 
JMP (SAS) to determine the statistical significance of the results. Physiologic 
experimental data were analyzed using the Student's t-test and one-way ANOVA 
with Tukey-Kramer method to compare means; behavioral data were analyzed 





CHAPTER THREE:  
RESULTS 
3.A. Endogenous Dopamine Appears to Play a Role in Control of C. elegans 
Nociceptive Behaviors 
To determine the neural-modulatory role of dopamine in the C. elegans 
chemosensory avoidance behavior, we assessed behavioral differences between 
wildtype and the dopamine deficient cat-2 mutant strains (See section 1.C.1). We 
tested a panel of known ASH-sensed soluble stimuli (See section 1.H.2.). When 
a drop of liquid containing a noxious substance is applied to a forward moving C. 
elegans animal it responds by a rapid reversal of direction. The data for 
responses were quantified in two ways: (1) a response was scored if the animal 
reverses direction within four seconds of being stimulated and is reported as a 
percentage of animals responding and (2) the actual time elapsed was recorded 
from presentation of stimuli to the beginning of a reversal of direction (Fig 5).  In 
most cases, wildtype animals will respond with a reversal in direction for nearly 
all animals tested. Dopamine deficient cat-2 mutant animals were observed to be 
less responsive to stimulation with glycerol and quinine in comparison to the 
wildtype animals. Only 50% of cat-2 animals responded to the glycerol stimuli 
compared to >75% of wildtype responding. A more robust difference was 
observed with the quinine stimuli, resulting in <20% of cat-2 animals responding 
compared to nearly 100% of wildtype animals responding. cat-2 animals 
responded better than wildtype animals when presented with 0.1% Cu2+; >85% 
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of cat-2 mutant animals responded more rapidly compared with only ~50% of 
wildtype animals responding. In summary, we found that for most of the 
repellents tested, the dopamine deficient cat-2 animals responded less to 
aversive stimuli; an interesting result was the increased response of the cat-2 
animals to the heavy metal Cu2+ in comparison to the wildtype animals. These 
results suggest that dopamine signaling may play a role in regulating C. elegans 
response to soluble aversive stimuli, although different stimuli may be regulated 
different ways (Fig. 8).  
To further confirm that the behavioral differences observed between the 
wildtype animals and the cat-2 animals could be attributed to a deficiency in 
dopamine, we asked whether exogenous dopamine could restore normal 
behavior to cat-2 mutant animals. We repeated the previous behavioral 
experiments but tested the animals in the presence of exogenous dopamine. 
There was no significant effect of the dopamine treatment on wildtype animals. 
The dopamine treatment yielded no significant difference in the behavior of the 
wildtype animals. The response of the cat-2 animals in the presence of 
exogenous dopamine was restored to the normal response observed with the 
wildtype animals (Fig. 9); with the addition of dopamine, ~90% of cat-2 animals 
responded to quinine. This led us to also evaluate response to quinine in dop-1 
and dop-4 mutant animals. As expected, both dopamine receptor mutants had 
poor responses to quinine; ~45% of dop-1 and ~55% of dop-4 animals 
responded to quinine. Exogenous dopamine treatment of the dopamine receptor 
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mutants had no effect on response (Fig. 9). These results suggest that dopamine 
is required for regulating quinine sensation. Also, these results show that 
dopamine can be applied to C. elegans exogenously to replace the missing 
endogenous dopamine, suggesting that dopamine may be functioning 
extrasynaptically as a neuro-hormone rather than as a traditional synaptic 
neurotransmitter. This is consistent with previous studies using volatile odors 
detected by ASH neurons (Baidya et al., 2014). 
3.B. Microfluidic Devices in Conjunction with G-CaMP Reporter Proteins Allow for 
the Quantification of Ca2+ flux within C. elegans Neurons 
To make a quantitative assessment of ASH neural activity in the C. 
elegans animals, we used a transparent microfluidics device (See section 1.J.) to 
immobilize the animals and to allow for the rapid application and removal of 
stimuli; the effects of the stimuli were quantified using the G-CaMP calcium 
reporter protein expressed in ASH neurons (See section 1.I.1.). The microfluidics 
device is mounted on a fluorescent microscope to enable us to create video 
recordings of the change in fluorescence signal upon stimulation of the animals. 
The various aqueous solutions that will be delivered to the animal within the 
microfluidics device are contained in a series of fluid reservoirs (Fig. 7 and 10). 
The flow channels in the microfluidics chip are connected to these reservoirs via 
small diameter tubing, allowing for the delivery of fluids to the animal being tested 
(See section 2.D.). The microfluidics device is also connected to a vacuum 
source, which drives fluid flow. The addition of small solenoid valves in-line 
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between the reservoirs and the microfluidics device allows for the rapid and 
precise switching of the fluids to which the animal is exposed. Animals at rest are 
exposed to a saline buffer or possibly an experimental treatment (i.e. exogenous 
dopamine) and activating a valve exposes the trapped animal to a stimulus. A 
closer look at the microfluidics device reveals the architecture of the worm trap 
that immobilizes the animal in such a way that the nose is exposed to the 
channel carrying the switchable fluid stream (Fig 10C). 
To determine the resolution of the G-CaMP reporter proteins in the 
evaluation of neural physiology we performed a series of experiments with C. 
elegans to develop a procedure to quantify the activity of the ASH neuron. For 
physiological recording experiments, we have used a strain of worms that 
expresses the transgenic G-CaMP reporter proteins within the ASH neurons in 
an otherwise wildtype background using the sra-6 promoter (sra-6::G-CaMP). We 
measured Ca2+ flux as a proxy for the physiological response of ASH neurons to 
stimulation with 1M glycerol. The fluorescence trace shows the average values of 
the ASH neurons physiologic activities (Fig. 11A). To normalize the data, we 
averaged twenty seconds of fluorescent signal while the neuron is at rest to 
represent a baseline of activity; all the data points for an individual video 
recording are then normalized by this baseline value to show an increase in 
fluorescence as a percentage. The normalized data are then averaged over 
multiple recordings from individual animals (n > 10). During the first twenty 
seconds of each recording the animals are exposed to saline solution only; next 
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the animals are exposed to the stimulus for a period of ten seconds, and lastly 
the animals are exposed to saline again (Fig. 11) this represents an entire data 
collecting recording. In later experiments we adapted this procedure to allow for a 
longer, 30 second, exposure to stimulus to further investigate the kinetics of the 
ASH neuron’s activity. 
Is there an observable difference in the physiological activity of the ASH 
neuron associated with the level of endogenous dopamine within an individual 
animal?  By utilizing a strain carrying the transgene in a cat-2 background (cat-2; 
sra-6::G-CaMP), we can further understand the effects of dopamine on the ASH 
mediated behaviors (Fig. 12). The dopamine deficient cat-2 mutant strain is 
known to produce ~40% less dopamine compared to wildtype animals (Sanyal et 
al., 2004), The sra-6::G-CaMP animals responded to the glycerol with a ~150% 
increase in normalized fluorescence intensity over the baseline (Fig 12A). cat-2 
sra-6::G-CaMP animals responded to the glycerol stimulus with a ~145% 
increase in normalized fluorescence signal, which was not significantly different 
from the way that the sra-6::G-CaMP responded (Fig. 12B).  This line of 
experimentation failed to yield data indicating a significant difference in the peak 
fluorescence, as determined by students t-test, in the ASH neuron response as 
measured as Ca2+ flux in the presence or absence of endogenous dopamine. 
However, the data does suggest that we have developed a means to quantify the 
activity of the ASH neurons; our quantified ASH activity traces resemble those of 
multiple published works (Chronis et al., 2007; Hilliard et al., 2005). 
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3.C. Dopamine Activity is Diminished in the Presence of Salt 
C. elegans exhibits a thrashing behavior when placed in water. 
Interestingly the addition of dopamine to water will paralyze the animals 
eliminating the thrashing behavior. This assay is known as swimming induced 
paralysis (SWIP) (Hardaway et al., 2012; McDonald et al., 2007). We have 
utilized this behavior to determine the activity of dopamine when suspended in 
the isotonic saline buffer solution M13 (see Materials and Methods), as M13 is 
used as the standard recording buffer and will therefore be used to deliver 
dopamine to animals trapped within the microfluidics device in our proposed 
experiments. We found that the biological ability of dopamine to render C. 
elegans animals paralyzed is diminished when the dopamine is suspended in 
M13. 4 mM dopamine dissolved in polished H2O can paralyze >50% of animals 
within 3 minutes of application. The paralyzing effects of dopamine was 
diminished when the dopamine was dissolved in M13. When the dopamine is 
dissolved in the M13 the concentration of dopamine must be increased to 300 
mM to induce the same level of paralysis as 4 mM dopamine in water (Fig. 13A). 
We assessed what solutes within the M13 recording buffer are responsible for 
the diminished activity of dopamine in this assay by individually testing each 
component of the M13 buffer with dopamine and assessing paralysis. Our data 
indicates that both KCl and NaCl have an adverse effect of the ability of 
dopamine to render the animals paralyzed; in the presence of either salt nearly 
zero animals were paralyzed. The Tris buffer had no effect on the activity of 
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dopamine; nearly 100% of animals treated with dopamine and Tris buffer were 
rendered paralyzed (Fig. 13B). The data generated from the SWIP assays have 
given us a working concentration of dopamine (300 mM) to match the activity of 4 
mM dopamine in water.. 
3.D. ASH Neuron Response to Quinine  
Although we did not find any difference in ASH Ca2+ response between 
wildtype and cat-2 mutants when using glycerol, we decided to test if we could 
detect a difference using quinine instead, as behavioral response to quinine in 
the drop assay exhibited the most robust difference between wildtype and cat-2 
(Fig. 8) (See section 3.A.). We initially used 10 mM quinine as stimulus for Ca2+ 
recordings because this concentration provided robust responses in behavioral 
experiments. However, stimulation with 10 mM quinine did not yield any 
detectable response. To remedy this problem, we attempted experiments with 
increasing concentrations of quinine. 50 mM quinine yielded results that we were 
able to quantify and so this became our stimulus concentration for all future 
recording experiments. 
We measured transient changes in intracellular [Ca2+] in C. elegans ASH 
sensory neurons in response to chemical stimuli quinine (See section 3.A.)  For 
each experimental condition we obtained recordings from 20 individuals. We 
initially analyzed the recording traces to establish the intensity of response; after 
many iterations of the experiment, it became clear that certain individuals simply 
did not respond. One explanation for this is that animals not producing a 
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response might be damaged/injured in the microfluidics chip loading process (but 
see also Discussion). We chose to exclude these responses from our statistical 
analysis, but we report fractions of animals responding. We set a threshold of 
>20% increase in peak fluorescent signal to include a trace in the statistical 
analysis. We then analyzed the traces to determine the following metrics (Fig. 
14). The peak fluorescence of response was measured as the maximum 
percentage increase in fluorescence signal over the established baseline resting 
level. The total time of response was measured as the amount of time that the 
fluorescence signal was greater than that of the pre-stimulus baseline. The 
integral of the traces was measured as the area under the trace between 
application of stimulus to when fluorescence level returns to pre-stimulus 
baseline. The slope of the initial increase in fluorescence signal is measured as 
the initial slope of response. We also measured the time elapsed from stimulus 
initiation to the peak fluorescence as the time to peak. Prior to analysis the traces 
were normalized to zero using the pre-stimulus rest period data points. These 
metrics were used to evaluate the activity profiles of the ASH neurons.  
We found that ASH neurons in wildtype animals (n=17/20) responded with 
a significantly greater peak of fluorescence (111.3% ± 13.2 Δƒ⁄ƒ) in comparison 
to cat-2 animals (n=7/20) (56.8% ± 16.6 Δƒ⁄ƒ) and the integrals of response 
(34914.8 ± 5572.6 (Δƒ⁄ƒ)∙(seconds))  and (16339.4 ± 6985.6 (Δƒ⁄ƒ)∙(seconds)) 
respectively, as expected based on initial behavioral experiments. There was no 
statistical difference between the ASH neurons total time of response, slope or 
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time to peak fluorescence between wildtype (Fig. 15A and 16) and cat-2 (Fig. 
15B and 16). Interestingly, the fraction of ASH neurons in wildtype and cat-2 
animals responding to quinine in this experiment resembled the fraction of 
animals of their respective genotypes that respond behaviorally (see section 
3.A.). The data suggests that endogenous dopamine signaling affects the overall 
magnitude of Ca2+ flux in ASH neurons in response to quinine without changing 
the overall kinetics. 
3.E. Exogenous Dopamine Restores Normal ASH Response of cat-2 Animals 
We next tested the ASH response of dopamine treated animals for 
comparison with non-treated animals. SWIP assay data (see section 3.C.) 
indicated the need to greatly increase the concentration of dopamine to maintain 
physiologic functions in the M13 buffer solution. However, early experiments 
using the 300 mM dopamine-M13 solution gave rise to technical problems. 
Usually in a typical recording experiment, we are able to process several animals 
allowing for the acquisition of several traces using a single microfluidics chip. 
Individual animals are injected into the microfluidics chip, tested, and then 
expelled using syringe to push the worm out of the trap and eventually into the 
vacuum (port 2); a second worm can be then loaded and the process repeated. 
Using 300 mM dopamine we were only able to test a single animal per 
microfluidics chip, as each animal became stuck just outside of the trap never 
arriving at the vacuum port. We believe the excess dopamine created a more 
viscous solution not allowing for the ejection of the tested animal. We also 
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viewed this dramatically increased concentration of dopamine as unrelatable to 
the significantly lower concentrations of 4 mM used in behavioral assays. To 
remedy problems of viscosity and of potential unrealistic dopamine 
concentrations, we decided to attempt treatment with the 4 mM concentration of 
dopamine-M13 solution, even though 4 mM M13 showed little activity in the 
SWIP assay. We knew from the previous SWIP assays that the stability of the 
dopamine in the M13 buffer declined over time, but would it remain stable 
enough over the short term to allow for treatment of animals?  To ensure that 
each dopamine treatment had equivalent effects we created the 4 mM dopamine 
M13 solution immediately prior to each experimental trail and completely flushed 
the previous treatment mixture from the system prior to proceeding with the next 
trial. This was a time-consuming process but much more efficient that the 
experimental trials with the 300 mM dopamine M13 solutions. Exogenous 
dopamine was perfused within the microfluidics recording rig for a period of 60 
seconds prior to running the before mentioned experimental recording procedure. 
As seen in figures 15B and 16A, 4 mM dopamine treated cat-2 animal ASH 
neurons (n=9/20) responded with a significantly greater peak fluorescence 
(263.0% ± 55.5 Δƒ⁄ƒ) when compared to non-treated cat-2 animals (Fig. 15D and 
16A) ASH responses (n=7/20) (56.8% ± 16.6 Δƒ⁄ƒ). We also observed a 
significant difference in the integral of the ASH response traces when comparing 
the dopamine treated cat-2 animals (79868.8 ± 17891.6 (Δƒ⁄ƒ)∙(seconds))  with 
the non-treated cat-2 animals (16339.4 ± 20287.1 (Δƒ⁄ƒ)∙(seconds)): a ~480% 
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increase (Fig. 16C). We observed no significant difference in the comparison of 
the following metrics: total time of response, slope, or time to peak fluorescence 
as seen in figures 16. We continued with the 4 mM dopamine treatment of 
wildtype animals. Comparing dopamine treated (n=13/20 ) (193.9% ± 39.49 Δƒ⁄ƒ) 
versus non-treated (17/20) (104.2% ± 41.1 Δƒ⁄ƒ) wildtype animals (Fig 15A,C 
and 16A), ASH responses to 50 mM quinine revealed a wider variance in 
response but not a statistically significant difference in the means. Again, we 
observed no significant difference in any of our comparative metrics as seen in 
figure 16. This data suggests that exogenous dopamine treatment partially 
restores normal ASH activity in dopamine deficient cat-2 animals. 
We next compared 4 mM exogenous dopamine treated wildtype and cat-2 
animals. We observed no significant differences in the peak fluorescence, total 
time of response, the integral, slope or time to peak between wildtype and cat-2 
ASH neurons as seen in figure 16. Interestingly, the OFF response in dopamine-
treated cat-2 animals was greatly increased. These data further suggest that 
endogenous dopamine influences ASH neuron activity in response to quinine, 
although the exogenous dopamine treatment of dopamine deficient cat-2 mutants 
does not fully recapitulate the wildtype response. 
3.F. ASH Neurons in DOP Receptor Mutants Respond to Quinine more Robustly 
than Wildtype Animals 
With good evidence supporting the hypothesis that dopamine plays a 
regulatory role on the ASH neuron activity we further desired to understand what 
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dopamine receptors may be at play in this regulatory pathway. As previously 
discussed, good candidate dopamine receptors for investigation are dop-1 and 
dop-4 (See section 1.F.). We recorded ASH Ca2+ response traces to 50 mM 
quinine for both dop-1 and dop-4 mutant strains of C. elegans animals. We first 
compared the ASH response curves between dop-4 mutant animals (Fig. 15F) 
with that of wildtype animals (Fig. 15A). The ASH response trace of dop-4 
animals (n=17/20) showed no significant differences in the metrics of peak 
flouirescence, slope, integral of response, total time of response or the time to 
peak fluorescence when compared to wildtype animals as seen in figure 16. We 
also observed significant differences in peak fluorescence between dop-1 
animals (Fig. 15E) (n=19/20) (556.1% ± 69.5 Δƒ⁄ƒ) and wildtype animals (Fig. 
15A) (n=17/20) (104.1% ± 87.5 Δƒ⁄ƒ) (Fig. 16A). This difference was massive - a 
greater than a 4-fold increase.. Next, we observed a significant difference in the 
integral of the curves between dop-1 animals (168447 ± 29128.9 
(Δƒ⁄ƒ)∙(seconds)) and wildtype animals (34915 ± 38282.9 (Δƒ⁄ƒ)∙(seconds)) (Fig. 
16C); the dop-1 ASH response had a ~480% increase in the integral compared 
to wildtype animals. Additionally, we observed a significant difference in the initial 
slopes of the curves comparing dop-1 animals (44.1 (Δƒ/ƒ)⁄(sec.) ± 10.0)  and 
wildtype animals (9.1 (Δƒ/ƒ)⁄(sec.)  ± 12.6) (Fig. D). Lastly, we observed a 
significant difference in the time to peak fluorescence between dop-1 (24.7 ± 2.3 
seconds) animals and wildtype (24.5 ± 2.9 seconds) animals as seen in figure 
16. Finally we compared the ASH response profiles to 50 mM quinine between 
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dop-1 (Fig. 15E) (n=19/20) and dop-4 (Fig. 16F) (n=17/20) mutant animals. We 
observed a significant difference while comparing the peak fluorescence of dop-1 
animals (556.1% ± 72.0 Δƒ⁄ƒ) and dop-4 animals (314.5% ± 79.1 Δƒ⁄ƒ) (Fig. 
16A). We found no additional significant difference in any of the remaining 
metrics of total time of response, the integral of the curves, the initial slopes of 
the curves, or the time to peak fluorescence comparing dop-1 animals to dop-4 
animals as seen in figure 16. Contrary to our initial expectations these data 
suggest the DOP receptor mutants have a more robust Ca2+ response in ASH 




CHAPTER FOUR:  
DISCUSSION 
The experiments described above in Chapter 3 strongly suggest that 
dopamine influences the response of the ASH neurons to the noxious stimuli 
quinine. Behavioral experiments revealed significant differences in the behavior 
of C. elegans animals with different levels of endogenous dopamine; treatment of 
dopamine deficient cat-2 mutants with exogenous dopamine restored behaviors 
to resemble those of normal animals (Fig. 7). ASH neurons are known to detect 
noxious environmental stimuli such as quinine (Bargmann, 2006; Ezak and 
Ferkey, 2010), yet the question remains as whether dopamine influences the 
activity of the ASH neurons causing the behavioral differences observed. In 
physiological experiments utilizing the G-CaMP fluorescent reporter to provide a 
Ca2+ flux trace as a proxy for neural activity, we were able to demonstrate that 
treatment with exogenous dopamine restored the Ca2+ activity of the ASH 
neurons in cat-2 dopamine deficient animals to that of wildtype animals (Fig. 15C 
and 16).  
Early behavioral experiments within our lab revealed that M13 recording 
buffer substantially reduced the activity of dopamine. SWIP assay data (see 
section 3.C) suggested that the ability of dopamine to render the animals 
paralyzed was greatly diminished at standard 4 mM concentrations in the 
presence of the M13 recording solution. To get around this problem, we asked 
whether greater concentrations of dopamine in the M13 buffer could elicit the 
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same effects observed with lower concentrations of dopamine in H2O; 
experiments revealed that 300 mM dopamine in M13 had the same paralytic 
effects as 4 mM dopamine in water. With this new “working” combination of 
dopamine and M13 buffer we attempted to treat animals within the microfluidics 
chip, but this approach proved to be problematic. Experimental throughput was 
severely impacted as only one animal was able to be processed through each 
microfluidic chip after which the chip became unusable, requiring a time-
consuming switching and preparation of microfluidics chips in between trials. 
Something about this high concentration of dopamine was causing animals to 
become stuck within the microfluidics chip; we hypothesized that the solution had 
become more viscous or sticky causing the animals to become stuck. We also 
hypothesized that the paralytic effect of the dopamine may play a role in 
preventing the animals from being ejected from the microfluidics chip.  
This left us in a predicament; we desired to treat the animals with 
dopamine inside of the microfluidics chip, but to maintain separation of fluid flows 
within the microfluidics chip as well as to maintain similar osmotic concentrations, 
the dopamine had to be delivered in the M13 solution. The SWIP assay 
presumably targets ventral cord motor neurons that are known to express 
dopamine receptors (Hardaway et al., 2012; McDonald et al., 2007). Previous 
experiments showed that lower concentrations of dopamine in M13 could 
influence ASH driven behavior (see section 3.A.) (Ezak and Ferkey, 2010), which 
are done on NGM plates that contain similar salt concentrations as M13 buffer. 
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The ASH neurons are also amphid neurons (see section 1.D.6.) with sensilla that 
are directly exposed to the microfluidic buffer stream, as opposed to the ventral 
cord motor neurons that are located more posteriorly and therefore "shielded" by 
the PDMS chip. If dopamine receptors are expressed in ASH, it is possible they 
would be more accessible to dopamine in the buffer stream even at lower 
effective concentrations. Given these considerations, we attempted to use lower 
concentrations of dopamine in M13 in our recording chip to see if we could 
observe any effects. This approach allowed for successful exogenous dopamine 
treatments in the microfluidics chip, providing data that clearly and significantly 
illustrated the effect of dopamine on the ASH neurons (see section 3.E).  
We observed some differences between our ASH Ca2+ recordings and 
similar previously published data. As discussed in section 1.H. the ASH neurons 
exhibit a peak of activity at the onset (the ON response) of stimulus that rapidly 
decays but does not return to baseline; the neuron shows a steady and elevated 
level of Ca2+ until the stimulus is removed. The removal of the noxious stimuli 
triggers an OFF response, which is characterized by another spike in intracellular 
Ca2+ followed by a rapid drop-off back to baseline (Chronis et al., 2007; Hilliard et 
al., 2005). This ON/OFF response was characterized using glycerol (i.e., 
hyperosmotic shock) as a stimulus for ASH neurons. ASH neurons were also 
shown to have a Ca2+ response to quinine (Hilliard et al., 2005), although an 
ON/OFF response was not observed in that study. Overall, the recordings we 
obtained using quinine were grossly similar to published results. Our ASH traces 
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of both wildtype and cat-2 animals had the marked ON and OFF response peaks 
to application and removal of quinine but the ON response was more persistent 
and did not decay as quickly. The amplitude of our Ca2+ peaks (~80% increase) 
were also lower than reported values for ASH neurons (~180% increase). 
There might be several explanations for these discrepancies. In Hillard et 
al (2005) a different Ca2+ sensitive reporter protein cameleon was used to 
measure quinine responses. Cameleon uses a different mechanism for Ca2+ 
induced fluorescence than G-CaMP (Looger and Griesbeck, 2012). Furthermore, 
cameleon reporters are sensitive to motion artifacts, and worms are physically 
glued to an agar pad to facilitate recording; this may have affected ASH neurons 
in some way that obscured an ON/OFF response. We adapted the microfluidics 
chip approach that Chronis et al (2007) used and saw a similar ON/OFF 
response for quinine as they did for glycerol, suggesting that an ON/OFF 
response is a general feature of ASH neurons. The differences in the decay of 
the ON response might be attributable simply to differences in stimuli (glycerol vs 
quinine). Finally, although we used (from a behavioral standpoint) a very strong 
stimulus of 50 mM quinine, the amplitude of the Ca2+ spike was relatively weaker 
than previously reported for ASH neurons. We note that our preliminary 
experiments with glycerol were also substantially weaker than published results 
(Fig. 12) and we did not observe ON/OFF responses with glycerol treatment 
even using the microfluidics chip. It is possible that local environmental 
conditions in our lab simply yield weaker ASH responses in general.  
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Our data suggests that treatment of dopamine deficient cat-2 with 
exogenous dopamine can increase the overall activity of the ASH neuron in 
response to the noxious stimulus quinine; this increase in activity grossly 
resembles that of the ASH activity of exogenous dopamine treated wildtype 
animals (Fig. 15). Similar to published works we saw a near doubling in the 
amplitude of exogenous dopamine treated wildtype animals in comparison to 
non-treated animals (Ezcurra et al., 2011) (Fig. 15). That exogenous dopamine 
can increase Ca2+ activity in wild type animals is not surprising, given that it takes 
at least 5 minutes to load an animal into the microfluidics chip, during which it is 
not exposed to food. cat-2 ASH activity was increased to a similar peak and 
overall general activity as wildtype; this represents a nearly 400% increase in 
comparison to non-treated cat-2 ASH activity. In addition, ASH activity observed 
in dopamine treated cat-2 animals had grossly exaggerated OFF responses 
when compared to the ON response. This was evident when comparing our 
wildtype results or with other published data (Chronis et al., 2007; Hilliard et al., 
2005). Even though we do not see the same OFF response increase in wildtype 
animals, we also do not see the same percentage increase in overall ASH 
activity; this indicates that the exogenous dopamine treatment had a stronger 
effect on ASH activity in cat-2 mutant animals. It is therefore reasonable to 
conclude that exogenous dopamine treatment largely restores normal ASH 
neuron Ca2+ response to quinine in cat-2 mutants, and that the differences 
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between cat-2 and wild type ASH neuron Ca2+ responses can be attributed to a 
dopamine deficiency. 
Interestingly, when we tallied the percentage of animals responding with 
increased ASH Ca2+ activity in relation to quinine stimulation, we observed that 
the data closely resembled that of the behavioral data; nearly all wildtype animals 
responded in both behavioral and physiological experiments whereas less than 
half of cat-2 animals responded. This trend continued as we treated the animals 
(both cat-2 and wildtype animals) with exogenous dopamine. These results may 
indicate that although we observed an increase in the Ca2+ activity of the cat-2 
ASH neurons, this does not necessarily mean that this would in fact elicit a 
change in behavioral response. A trivial explanation for this observation is that 
the fraction of animals responding in the Ca2+ recordings is just an artifact 
caused by experimenter handling; this is possible, but we do not think this is the 
case. One possible explanation is the exogeneous dopamine we added may 
have restored Ca2+ flux amplitude but not probability of firing in ASH neurons. In 
such a scenario, exogenous dopamine would also have to activate other sensory 
neurons to detect quinine when ASH does not fire. C. elegans alters the sensory 
neurons used to detect volatile chemical repellants depending on serotonin levels 
(Chao et al., 2004), so this is not without precedent. Also, the ASK neurons are 
also known to be quinine sensing neurons (Hilliard et al., 2004). This implicitly 
suggests that dopamine must have multiple cellular sites of action; it is therefore 
useful to consider dopamine receptors.  
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Both dop-1 and dop-4 mutant strains were shown to respond to the 
quinine stimulus less frequently than wildtype animals in behavioral assays (See 
section 3.A.). Unlike cat-2, both mutant strains responded reliably in Ca2+ 
recordings (about 7-9 responses vs. 17-19 responses per 20 trials, respectively). 
Much to our surprise, the dopamine receptor mutants had far more robust Ca2+ 
responses, showing a ~250-400% increase in ASH activity in comparison to 
wildtype animals. The Ca2+ recording data suggests a down-regulatory role for 
dopamine receptors in the activity of the ASH neurons in response to quinine 
stimulation; but the behavioral results suggest that these dopamine receptors up-
regulate ASH-mediated aversive behaviors (See section 1.H.2. & 3.A.). In other 
words, an increase in the activity of the ASH neurons does not necessarily 
equate to an increase in aversive behaviors.  
The idea that dopamine might have multiple cellular sites of action is 
consistent with this discrepancy we observed in the dop-1 and dop-4 mutants. 
For instance, dopamine might dampen ASH activity, but dopamine might also 
activate other downstream neurons that promote behavioral output. In this 
scenario, deleting the dopamine receptors would result in a net decrease of 
behavioral output because of a downstream bottleneck, even though ASH Ca2+ 
activity is increased. Alternatively, Ca2+ activity in ASH neurons does not directly 
correlate with behavioral output. In this scenario, dopamine receptors also 
dampen ASH activity, but large increases in intracellular Ca2+ actually result in 
less neural output. For instance, ASH neurons also use neuropeptides as 
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neurotransmitters, and neuropeptides usually are released with increased 
presynaptic activity (Ezcurra et al., 2016). Admittedly, all this is difficult to 
reconcile with these results and those of the cat-2 mutants with exogenous 
dopamine treatment.  
As shown, our experiments support the hypothesis that dopamine plays a 
regulatory role on the ASH neurons, but a there does not appear to be a simple 
model that is consistent with all our data. Further understanding of this sensory-
behavioral network could possible shed light on the complex activities of 
dopamine signaling. Investigation of the other neurons in communication with the 
ASH neurons could provide insight into dopamine regulation outside of the ASH 
neurons themselves. We could first use a series of transgenes expressing 
dsRNA targeted against unc-13 using cell specific promoters. unc-13 codes for a 
protein associated with stabilizing other pre-synaptic vesicle docking proteins 
(Richmond and Broadie, 2002) and knocking down unc-13 activity by RNAi would 
block synaptic transmission(Grishok et al., 2005). By blocking synaptic 
transmission, the unc-13 mutation would allow for the systematic silencing of 
individual neurons that might regulate ASH. Using our new understanding of the 
activity of ASH in regard to dopamine sensitivity and detection of quinine, both in 
terms of behavior and Ca2+ response, we could identify neurons in which lack of 
synaptic transmission would alter ASH Ca2+ response patterns. For instance, 
ADL sensory neurons receive synaptic input from the CEPV dopaminergic 
neurons and send synaptic output to ASH neurons (Fig. 1). Knocking down unc-
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13 activity in CEPV or ADL might show if those connections are relevant in 
dopamine modulation of quinine response. Experiments such as this could help 
us understand the cellular location(s) of dopamine activity and regulation. 
We still do not have a clear understanding of the dopamine receptor 
expression patterns. Based on functional studies we assume at least some of 
them to be expressed on the ASH neurons (Ezcurra et al., 2016), but direct 
expression evidence is still lacking. Dopamine receptor expression has been 
shown in many other head neurons (Chase et al., 2004; Sugiura et al., 2005; Suo 
et al., 2003), and that is consistent with the idea these dopamine receptors may 
likely be active in other neurons to regulate this behavior. To further characterize 
the sites of action, one could attempt cell specific transgenic rescue of dopamine 
receptor mutants. For instance, the sra-6 promoter could be used to specifically 
rescue the dopamine receptors within the ASH neuron. This approach may allow 
for the understanding of which receptor is functioning in which neuron. Though 
the above-mentioned experiment could be useful in understanding the possible 
activity of these dopamine receptors in specific cells, it still does not describe the 
natural expression patterns of the dopamine receptors.  
To better understand the natural expression patterns of dopamine 
receptors, our lab is currently utilizing CRISPR technology by replacing the dop-4 
and dop-1 coding sequences with GFP reporter sequence in their natural 
chromosomal context (L. Velasquez Macedo, in preparation). It could be 
interesting to examine strains with multiple dopamine receptor mutants to 
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observe possible antagonistic relationships between the various dopamine 
receptor mutants. We observed that the D1-like DOP-1 and DOP-4 receptors act 
to down-regulate the activity of the ASH neurons, but we have yet to experiment 
with the dop-2 and dop-3 mutant strains. It is possible that the D2-like DOP-2 and 
DOP-3 receptors could act to up-regulate ASH activity and so may play an 
antagonistic role with the DOP-1 or DOP-4 receptors. Further examination of 
these dopamine receptor mutants may provide a better understanding of the 










Figure 1: A circuit diagram of a group of C. elegans sensory neural circuits (A); 
triangular shaped neurons represent sensory neurons, hexagonally shaped 
neurons are interneurons, the neurons colored in blue are those that express one 
or all dopamine (DA) receptors, and the neurons colored greens are those that 
are dopaminergic in natural, that is they are cellular sites of DA production and 
release. GFP reporter assay show the expression pattern of tyrosine hydroxylase 
(B), a key enzyme in the pathway leading to the production of dopamine 





Figure 2:  The amphid neurons of the C. elegans hermaphroditic animals are 
located within the head just posterior to the pharyngeal pump, these neurons 
(ASE, ASG, ASH, ASI, ASJ, ASK, ADF, ADL, AWA, AWB, AWC, AND AFD) 
represent the primarily sensory neurons of the animal; C. elegans express 
bilaterally symmetric amphid structures. There also exists a similar structure in 
the posterior end of the animals known as the phasmid, which contains sensory 
neurons (PHA, PHB, and PQR) as well (a). A more detailed illustration of the 
amphid pore reveals the structure and ordering of the sensory neurons (b); 
detailed illustrations show the structure of the amphid neurons dendritic sensilla 






Figure 3:  ASH sensory activity is likely driven by a number of cellular receptors. 
GPCRs are known to detect stimuli from the environment, in turn activating Gi 
like subunits within the cell. It is also possible that the TRPV channels 
themselves can be activated by external stimuli inducing a depolarization of the 
cell via the cation flux through open channels (Adapted from and reviewed in 




Figure 4: Genetically engineered Ca2+ sensitive calmodulin domain containing 
green florescent protein (G-CaMP) reporter proteins (Nakai et al., 2001) (A) allow 
for the quantification of neural activity within the C. elegans animals. The 
transgenically coded G-CaMP genes are expressed specifically in the ASH 
neuron (B). In regions of low Ca2+ concentrations the G-CaMP proteins fluoresce 
at a low intensity; the intensity increases proportionally to match increases in 




Figure 5: The drop test behavioral assay consists of a micro-droplet of repellent 
applied to a forward locomoting animal; responses are measured as a reversal of 




Figure 6:  An image of the template used to create the spincast microfluidics chip 
mask (Chronis et al., 2007). As seen, one mask contains information for the 
casting of 20 microfluidics chip in a single molding. The microfluidics chips are 




Figure 7: A diagrammatic figure of microfluidics device set-up, also pictured is an 
enlarged image of the microfluidics recording chip. The tubing marked “A” 
attaches to the chip at port 1; it is removed from the chip to pick up worms; this 
activity is achieved by the addition of a three-way Luer lock valve (G) controlling 
flow from the fluid reservoir (used to keep worm in position during recording) and 
the syringe used for manipulating the worms. The tubing marked “B” attaches to 
the chip at port 5; it delivers stimuli to the recording chip and is always placed to 
the opposite side of the worm trap. The tubing marked “C” attaches at port 3 and 
“D” attaches at port 6; tubing “C” and “D” are derived from the same fluid 
reservoir but utilize an electronic switching solenoid (1)1 to alter the flow of fluids 
with the recording chip provide rapid exposure and elimination of stimuli. The 
tubing marked “E” attaches to the chip at port 4; it is derived from two separate 
reservoirs, one containing M13 and the other the dopamine suspended in M13; 
the switching solenoid (2) has been run in reverse in comparison to solenoid 1.  
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Figure 8: cat-2 mutant animals respond differently than wildtype animals to water 
soluble stimuli.  We found significant differences to the response of WT and cat-2 
dopamine deficient mutants to 0.1 mM Cu2+, 1M glycerol and 5 mM quinine. 
These two strains exhibited no difference in response to either 0.1% SDS or the 
M13 buffer (negative control).  
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Figure 9: Exogenous dopamine restores normal behavior to cat-2 animals 
stimulated with 5 mM quinine, shows no effect on the dop-1 or dop-4 animals 
(data obtained by J. Jensen). Worms were tested on NGM plates that had been 
treated to achieve 4 mM dopamine concentration, untreated plates and treated 
plates with an M13 negative control stimuli. We found significant differences in 
the untreated assays, yet no significant difference in the treated assays indicating 
a significant effect on the worms’ behavior.  
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Figure 10: The microfluidics rig is set up to run over the inverted fluorescent 
microscope with an accompanying fluorescent dissecting microscope to enable 
selection and transfer of subject animals (A). A close up of the recording rig 
shows the tubing supplying the microfluidics chip with buffers and stimuli (B). The 
microfluidics chip has a total of 6 ports: 3 ports for buffer flow, one for stimuli, one 
for worm loading, and one for the vacuum line (C).  
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Figure 11: Transient Ca2+ recordings from the ASH neuron allow for the 
quantification of neural activity levels during stimulation. Data obtained during 
recordings can be averaged and normalized to create activity traces (A). An 
individual C. elegans animal is held in place within the microfluidics chip in such 
a way as to have the rostral end of the animal exposed to the fluid streams; in 
this position, the animal can be exposed to the M13 buffer (B) or to an aqueous 
solution, drug or stimuli (C).  
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Figure 12: Using glycerol as a stimulus we characterized the response of the 
ASH neurons in both wildtype (A) and cat-2 (B) animals; bold lines are that of the 
average response (n=10) and the thinner lines that of +/- the standard deviation. 
We reported no significant difference in the maximum intensity of response 




Figure 13: Dopamine (DA) renders C. elegans animals paralyzed during a SWIP 
assay. However, when dopamine is suspended in M13 recording buffer this 
paralysis dissipates (A). The salts found in the M13 recoding buffer disrupt the 




Figure 14: An illustration of the metrics measured with the obtained Ca2+ 
recordings. The dark green represents the measure of peak fluorescence, Δf/f is 
a relative measure of the increase in fluorescence over that of the baseline 
fluorescence. The red color represents the total time of response as far as the 
total time that fluorescence is above baseline. The blue color shows the measure 
of time from stimuli application to peak fluorescence. The black color shows the 
measure of the initial slope to the response trace. Lastly, the grey trapezoid 





Figure 15: ASH neuron Ca2+ changes in response to 50 mM quinine stimulation. 
The red bar indicates period of stimulation (30 sec). Ca2+ response trace of (A) 
wildtype animals (n=17/20; fraction of animals responding versus tested), (B) cat-
2 animals (n=7/20), (C) wildtype animals treated with 4 mM exogenous dopamine 
(+DA) (n=13/20), (D) cat-2 animals treated with 4 mM exogenous dopamine 
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Figure 16: legend on following page. 
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Figure 16: (previous page) T-test and ANOVA statistical analysis of the ASH 
response to 50 mM quinine in a variety of genetic backgrounds. Dots indicate 
outliers but are included in the analysis. (A) We observed a significant difference 
in the peak fluorescence of the Ca2+ traces between the (n=17/20; fraction of 
animals responding versus tested) wildtype and (7/20) cat-2 animals (p=0.0118). 
ANOVA (α≤0.05) revealed a difference among wildtype cat-2, dop-1 and dop-4 
(F<0.0001). The Tukey-Kramer method of comparison identified significant 
differences between cat-2 and dop-1 animals (p=0.0003), between wildtype and 
(n=17/20) dop-1 animals (p<0.0001), and between dop-1 and (n=19/20) dop-4 
animals (p=0.0343). (B) We observed no statistical difference in the total time of 
response of the Ca2+ traces. (C) We observed a statistical difference in the 
integral of the Ca2+ traces between cat-2 animals and wildtype animals 
(p=0.0162). ANOVA (α≤0.05) indicated significant differences among wildtype, 
cat-2, dop-1, and dop-4 (F=0.0016). The Tukey-Kramer method of comparison 
identified significant differences between cat-2 and dop-1 animals (p=0.0081), 
and between wildtype animals and dop-1 animals (p=0.0064). (D) ANOVA 
(α≤0.05) indicated a significant difference among wildtype, cat-2, dop-1, and dop-
4 (F=0.0181). The Tukey-Kramer method of comparison identified a statistical 
difference in the initial slopes of the Ca2+ traces between wildtype animals and 
dop-1 animals (p=0.0370). (E) ANOVA (α≤0.05) indicated significant differences 
among wildtype, cat-2, dop-1, and dop-4 (F=0.0694). The Tukey-Kramer method 
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of comparison identified a significant difference in time to peak fluorescence 






Sequence (5'-3') Orientation Strain Notes 
cat-2 #4 gcgaatgacgtcactcctatcg sense cat-2  left 
primer for 
e1112  
cat-2 #3 gagacatatgagctagcagtgg antisense cat-2  right 
primer for 
e1112 
oZY46 cagctctaaaacaattatggttcgt sense dop-1 left 
primer for 
vs101 





antisense dop-1 right 
primer for 
vs101 
oZY55 aatgttggcttacgggtctg sense dop-4 left 
primer for 
tm1392 
oZY56 aaaattaggtctcggcacagc antisense dop-4 internal 
primer 
tm1392  




Table 1: identification of all primers used for genotyping the various mutant 
strains used in this study. Primer names are specific to our lab. Sense/antisense 
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